Dr. Reddy's gets Brazilian approval for generic Ozempic

Dr. Reddy's Laboratories has received approval from Brazilian health authorities to market a generic version of the diabetes drug Ozempic, allowing the company to expand its portfolio in the Brazilian pharmaceutical market.

Detected & updated continuously · Source: Nebula